Our Science
With about 575 scientists, Aurigene has developed
deep expertise in various target classes >>More
Trackrecord
Track-record of over 35 programs in collaboration with some of the leading global Pharma partners >>More
Our Focus
A specialized, discovery stage biotech, developing novel and best-in-class therapies to treat Oncology & Inflammation >>More
News
- 14th Apr 2011: Debiopharm and Aurigene sign a...
- 13th Sep 2010: Debiopharm Group™ and Aurige...
- 9th Sep 2010: Aurigene and Pcovery in pact t...
- 1st Sep 2009: Aurigene Announces Completion ...
- 3rd Feb 2009: Aurigene Announced Significant...
- 24th Nov 2008: Aurigene in licensing agreemen...
- 25th Jun 2008: Aurigene Achieves 2nd Mileston...
- 25th Apr 2007: Orion and Aurigene to Collabor...
- 2nd Feb 2007: Discovery Collaborations with ...
- 28th Jun 2006: Agreement with Debiopharm on I...
Events
- 6th Apr 2013: AACR Annual Meeting 2013
- 12th Nov 2012: Bio-Europe
- 6th Nov 2012: 24th EORTC-NCI-AACR Symposium ...
- 12th Sep 2012: BIO India International Confer...
- 9th Sep 2012: 17th International IRA Confere...
- 2nd Sep 2012: 22nd International Symposium o...
- 18th Jun 2012: 2012 Bio International Convent...
- 6th Jun 2012: EULAR: Annual European Congres...
- 20th May 2012: 33rd National MedChem Symposiu...